Rehydralyte Clinical ORS from Japan
Rehydralyte clinical oral rehydration solution powder for institutional use, classified 3006.93.20. USMCA 9823.10.12 eligibility under note 10(b)(2) for Canada/Mexico origin. Hospital-grade dehydration therapy.
Duty Rate — Japan → United States
12.5%
Rate breakdown
9903.05.4912.5%Section 301 (forced labor) — Japan (col1 rate < 12.5 percent): MFN < 12.5% → total duty capped at 12.5%
Import Tips
• Facility registration with FDA required,USMCA docs must reference clinical ORS status,Cold chain validation documentation